Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover

CH Cheng, LR Chen, KH Chen - International journal of molecular …, 2022 - mdpi.com
Osteoporosis is a serious health issue among aging postmenopausal women. The majority
of postmenopausal women with osteoporosis have bone loss related to estrogen deficiency …

Gender differences in Latin-American patients with rheumatoid arthritis

C Barragán-Martínez, J Amaya-Amaya… - Gender medicine, 2012 - Elsevier
BACKGROUND: Data on the effect of gender in rheumatoid arthritis (RA) in non-Caucasian
populations is scarce. Latin America and the Caribbean (LAC) is a large population with …

Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of …

KA Coulson, G Reed, BE Gilliam… - JCR: Journal of …, 2009 - journals.lww.com
Objectives: This study examined a wide array of clinical factors to evaluate their influence on
fracture risk and T scores in women with rheumatoid arthritis (RA) and determine if women …

Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort

E McKeown, VP Bykerk, F De Leon, A Bonner… - …, 2012 - academic.oup.com
Objective. To characterize steroid use and compliance with glucocorticoid-induced
osteoporosis (GIOP) guidelines within a large early inflammatory arthritis cohort. Methods …

Glucocorticoid-induced osteoporosis

RA Adler, RS Weinstein, KG Saag - Osteoporosis, 2013 - Elsevier
More than 70 years ago, osteoporosis associated with endogenous glucocorticoid excess
was described by Harvey Cushing. More common is the increased fracture risk associated …

Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study

U Massafra, S Migliaccio, C Bancheri… - Journal of …, 2013 - Springer
Glucocorticoid-induced osteoporosis (GIO) is the most frequent cause of secondary
osteoporosis. GIO is linked to glucocorticoids (GC) daily assumption with maximum effect …

Longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica

A Naranjo, R López, B García-Magallón… - Rheumatology …, 2014 - Springer
The aim of this study was to analyze the longitudinal practice patterns of prophylaxis of
glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica (PMR) …

Glucocorticoid-induced osteoporosis and Cushing's syndrome

KG Saag, RA Adler, RS Weinstein - Marcus and Feldman's Osteoporosis, 2021 - Elsevier
Glucocorticoid-induced osteoporosis (GIOP) remains the most common form of drug-
induced osteoporosis. Patients may fracture at a different bone mineral density (BMD) …

[PDF][PDF] OSTEOPOROSIS INDUCIDA POR CORTICOIDES: PREVALENCIA DEL TRATAMIENTO PREVENTIVO EN LA POBLACIÓN DE UN SISTEMA CERRADO DE …

C Carrizo, G Vidal, L Plantalech - Actual Osteol, 2013 - osteologia.org.ar
El uso de glucocorticoides (GC) se asocia a pérdida de masa ósea e incremento del riesgo
de fracturas. Los objetivos del trabajo fueron establecer la prevalencia del tratamiento …

[HTML][HTML] Osteoporosis in men of the endocrinology outpatient clinic in Manizales city, Colombia✩

A Sánchez Lozada… - Revista Colombiana de …, 2019 - scielo.org.co
Introduction: Osteoporosis is a multifactorial disease that increases in prevalence with age,
and may be associated with fragility fractures. In Colombia there are few studies conducted …